Following the Ontario provincial government’s announcement on how recreational cannabis will be sold once it becomes legal on October 17, the cannabis industry offered a variety of reactions.

On Monday (August 13), Ontario’s Progressive Conservative government unveiled its approach to the sale of legal adult-use cannabis, saying it will offer consumers online-only service until the establishment of retail shops from private players starting in April 2019.


Minister of Finance Vic Fedeli stated that the provincial government does not intend to be in the business of owning a network of cannabis shops.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Cannabis industry members offer reactions

Charles Taerk, president and CEO of Faircourt Asset Management, said the delay from the provincial government for retail shops has negative implications in the short term.

However, Taerk is optimistic in the long term thanks to the decision by the province to drop the plan of a government monopoly on cannabis shops. The executive also said there is potential for investors to strengthen their positions in companies set to experience declines due to the delay.

“There will likely be some negative trends to the names in the sector as short-term estimates on revenues and earnings are adjusted and moved out 12 months,” Taerk said. “We believe there is likely an opportunity to add to certain positions during this weakness.”

David Clement, a Toronto-based North American affairs manager at the Consumer Choice Center, said the decision by Ontario to embrace private retail is a win for consumers and smart public policy.

Clement added that not having stores with the start of legalization in Canada means consumers will continue to buy cannabis from illegal dispensaries.

“Simply put, relying solely on online sales until April 1 isn’t an accessible enough model to sway people away from the black market,” Clement said. He suggested the province should fast track the application process to allow legal cannabis shops to be available on October 17.

Canadian licensed producer Aurora Cannabis (TSX:ACB) announced on Tuesday (August 14) that it has already singled out over 100 locations for Aurora-branded cannabis retail shops in Ontario.

Through its partnership with Alcanna (TSX:CLIQ), Aurora will seek to establish its network of shops across the province once licensing applications become available. In Alberta, the duo already plans to have 37 cannabis shops following legalization.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Toronto-based law firm Aird & Berlis said in an email newsletter that it is interested to see if Ontario will use any of the licensing restrictions planned by other provinces for retail operators.

In Alberta, no person or entity can own more than 15 percent of the retail licenses for the province, while Saskatchewan has a fixed limit of 51 shop permits, according to the law firm.

Stocks take a dive following Ontario’s decision

During Tuesday’s trading session, most of the major cannabis stocks took took a hit from the delay in retail sales for Ontario. Canopy Growth (TSX:WEED,NYSE:CGC) closed with an 8.25-percent decline despite having a clear entry into the retail space with its acquisition of Hiku Brands (CSE:HIKU).

Other stocks like Aurora, Aphria (TSX:APH) and Cronos Group (TSX:CRON,NASDAQ:CRON) were also down 9.8, 9.54 and 3.09 percent, respectively, after the closing bell on Tuesday.

The Horizons Marijuana Growers Index ETF (NEO:HMJR), which tracks small-market-cap cannabis stocks across North America, suffered a 5.68-percent drop, according to the Aequitas Neo Exchange live tracker.

Horizon’s fellow cannabis-focused ETF, the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ), was also down 4.52 percent at market close on Tuesday. This fund holds close to 40 of the major cannabis stocks in the market.

The Canadian Index from Arcview Group’s Marijuana Index was down 22.33 percent on Tuesday. This index tracks 17 Canadian cannabis stocks like the Hydropothecary Corporation (TSX:HEXO), Organigram Holdings (TSXV:OGI) and Auxley Cannabis Group (TSXV:XLY).

Every listing of the Canadian Index was down on Tuesday, except for CannTrust Holdings (TSX:TRST), which announced its financial results for the second quarter of 2018.

Canadian Index constituents from the Arcview Group’s Marijuana Index.

According to Bloomberg, Canaccord Genuity cannabis analyst Matt Bottomley said on Tuesday that the Ontario news will result in a “long-term gain” for cannabis companies and investors.

Canadian licensed producer support group offers response

Avtar Dhillon, board chair for the Cannabis Council of Canada, a group overseeing the interests of licensed producers in Canada, said this move from Ontario will create a “truly competitive and inclusive landscape that will allow for law-abiding companies to more quickly replace the bad apples in the cannabis space.”

The executive director for the association, Allan Rewak, said it removes the cost of brick-and-mortar retail from taxpayers and instead puts it on the private sector to deliver.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Hiku Brands is a client of the Investing News Network. This article is not paid-for content.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is pleased to announce that it has issued a total of 7,400,000 options pursuant to its incentive stock option plan (“Plan”) to management, employees and consultants. Each option entitles the holder to subscribe for one common share of the Company for $0.265 for a period of 5 years, subject to the terms of the Plan

The Company has also agreed to engage Aktiencheck.de AG, for €50,000 for a European marketing and news dissemination program. The length of such program depends upon the Company’s future news flow.

Keep reading... Show less
  • Company has received UK Continuing Professional Development (“CPD”) accreditation for its global education platform, Khiron Academy
  • UK medical professionals may now earn CPD credits through Khiron’s medical cannabis education program
  • The Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK, to increase patient access via medical cannabis education
  • As a leading international medical cannabis educator, nearly 1,000 medical professionals in Latin America and the United Kingdom have registered for, or completed, Khiron Academy training

 Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe is pleased to announce it has received UK Continuing Professional Development (“CPD”) accreditation for Khiron Academy, the Company’s global medical cannabis education platform.

Additionally, following its accreditation, the Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK and fellow founding member of Project Twenty21, to increase patient access through medical cannabis education initially. Khiron Academy will be made available to prescribers in the UK that have registered with Cellen’s MedCanHub, an emerging education portal. Cellen is market leader, widely recognized for also launching the UK’s first digital pain clinic, Leva.

Keep reading... Show less

TRACE’s plant-based and alkaline wellness products to expand into key markets of Japan, China and the Philippines

Emerging leader in innovative health and wellness beverages and consumer products, BevCanna Enterprises Inc . ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today its anticipated expansion into the Asia Pacific region, through its wholly-owned subsidiary Naturo Group. After completing a comprehensive market, distribution and partner assessment, the Company intends to initially launch its portfolio of TRACE health and wellness products in the key markets of Japan, China, and the Philippines, through multi-channel distribution outlets including e-commerce, retail, and wholesale.

Keep reading... Show less

Trulieve acquires dispensary permits from Solevo Wellness West Virginia LLC for $650,000

Trulieve Cannabis Corp . (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States and the largest cannabis company in Florida announced today that it acquired Solevo Wellness West Virginia LLC (“Solevo”) and its three West Virginia dispensary permits for $650,000 . Solevo was awarded two permits in Morgantown and one in Parkersburg in January 2021 as part of the West Virginia application process.

Keep reading... Show less

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) a wellness company that develops and sells sustainable, plant-based products, is pleased to announce that it’s Jusu Home and Body line is now available for purchase on Faire Wholesale Marketplace (“Faire” or “www.faire.com”), an online wholesale marketplace valued at US $2.5 billion. Jusu Home and Body products are currently featured in their “New Arrivals” section.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/80230_8c77c54544bf884c_001.jpg

Keep reading... Show less